Trust Skorpios serves as Executive at Akero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Trust Skorpios has executed 1 insider transactions totaling $71.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2022 involved selling 1,636,000 shares valued at $71.2M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 1, 2022 | AKRO | $71.2M | Sale | 1,636,000 | $43.50 | Discretionary |
Trust Skorpios currently holds 3,271,829 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Trust Skorpios has been a net seller of AKRO stock. They have purchased $0 and sold $71.2M worth of shares.
Trust Skorpios's most recent insider trade was on Dec 1, 2022, when they sold 1,636,000 shares at $43.50 per share.
Get notified when new Form 4 filings are submitted